Gregory Russotti - Jun 9, 2025 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
Title: Chief Technology and Manufacturing Officer
Signature
/s/ Douglas Carr, Attorney-in-Fact
Stock symbol
IPSC
Transactions as of
Jun 9, 2025
Transactions value $
-$327
Form type
4
Date filed
6/11/2025, 05:04 PM
Previous filing
Mar 12, 2025
Next filing
Sep 10, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Russotti Gregory Title: Chief Technology and Manufacturing Officer C/O CENTURY THERAPEUTICS, INC., 25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA /s/ Douglas Carr, Attorney-in-Fact 2025-06-11 0001867305

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IPSC Common Stock Sale -$327 -526 -0.13% $0.62 392K Jun 9, 2025 Direct F1
holding IPSC Common Stock 92.8K Jun 9, 2025 By Gregory Russotti 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Remarks:

Title: Chief Technology and Manufacturing Officer